Whole Exome Sequencing (WES) leverages targeted capture technology to focus on protein-coding regions of the genome. Compared to whole-genome sequencing, WES offers more precise targeting, deeper coverage, and higher data accuracy - delivering an optimal balance of performance, efficiency, and cost-effectiveness.
Although the human exome represents only ~1% of the genome, it harbors approximately 85% of known disease-associated variants, making it a critical functional region. WES has therefore become a foundational tool across a wide range of applications, including genetic disease research, oncology companion diagnostics, pharmacogenomics, large-scale cohort studies, species identification, and paleogenomics.
Comprehensive Exome Solutions by Dynegene
Dynegene provides a versatile portfolio of human whole-exome solutions designed to meet diverse research and clinical needs. By optimizing key performance parameters - including capture efficiency, uniformity, sensitivity, accuracy, and cost - we enable researchers to achieve reliable and high-quality results across multiple application scenarios.
Exome Sequencing Workflow

Dynegene Human Exome Portfolio

● QuarStar Human All Exon Probes 4.0 (Standard)
• Designed based on the latest RefSeq, CCDS, and GENCODE databases, achieving
near-complete coverage of key reference regions;
• Advanced hybrid probe strategy combining high-performance dsDNA probes (enabled by single-base parallel amplification labeling technology) with chip-synthesized ssDNA probes;
• Supports flexible spike-in of customized target content for extended applications.

● QuarStar Human All Exon Probes 4.0 (Tumor)
• Optimized for oncology research with enhanced coverage of 1,000+ cancer-related genes, gene fusions, MSI, HRD, and HLA regions (~46 Mb total target region);
• AI-driven probe design, boosting strategies and high-performance dsDNA probe synthesis achieve a better bait-to-target ratio, enhancing capture specificity and uniformity while reducing sequencing burden and overall cost.

● QuarStar Human All Exon Probes 4.0 (Heredity)
• Comprehensive and up-to-date coverage: Leverages the latest versions of leading databases to achieve nearly 99.5% coverage of core exonic coding regions.
• More Stable Performance: Industry-leading GC bias control, exceptional on-target rates even at high coverage depths, precise coverage of differential regions, superior uniformity, and highly confident variant detection.
• Full-transcript coverage for over 40 frequently mutated complex genes improves detection of complex variants and rare diseases.

● QuarStar Human All Exon Probes 1.0
• Classic patented double-stranded RNA probes with upgraded manufacturing process.
• Building on the high detection rate of double-stranded RNA probes, our AI-powered boosting strategy further enhances capture performance while reducing data volume requirements.
• High data consistency, ideal for large cohorts and long-term research.

● QuarStar Human All Exon Probes 3.0(RNA)
• Comprehensive CDS region coverage based on RefSeq, CCDS, GENCODE and other databases.
• Delivers excellent performance in capture efficiency and uniformity, widely applicable for diagnosis of genetic disease, precision oncology, immunotherapy and other applications.